“…As for host-based markers, there have been attempts to tailor multiple measurements to predict the risk of specific age-related diseases, including cardiovascular diseases [ 67 , 117 , 118 ], type 2 diabetes [ 119 , 120 ], neurodegenerative disorders [ 52 , 121 ], and cancer [ 122 , 123 ]. While there is controversy regarding the ability of the DNA-methylation-derived epigenetic clocks to predict cardiovascular outcomes [ 67 , 117 ], measures of post-translational modifications by arginine methylation in human hair proteins have been suggested to be useful in that regard [ 118 ]. Despite the intriguing results and advantages of the noninvasive sampling method, this method does not appear to be better than existing ones and is, in any case, not suitable for the elderly suffering from baldness.…”